Quantcast

Latest Retina Implant AG Stories

2014-09-15 04:21:15

Professor Eberhart Zrenner Leads Discussion of Alpha IMS Patient Results One Year Post Implantation at Europe's Largest Ophthalmology Conference LONDON, Sept. 15, 2014 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that Professor Eberhart Zrenner, Retina Implant's co-founder and lead clinical trial investigator and founding director of the Institute of Ophthalmic Research, University of...

2014-08-11 04:21:59

Potentially Life-Changing Subretinal Implant Now Available at Six Leading Eye Clinics Across Germany REUTLINGEN, Germany, Aug. 11, 2014 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that the Company's Alpha IMS microchip was granted NUB innovation status and will now be reimbursed by Germany's statutory health insurance system. Insuring 90 percent of the country's citizens, the German...

2014-06-30 04:21:34

Professor Eberhart Zrenner Discusses the Future of Artificial Vision at Premier International Ophthalmology Meeting PARIS, June 30, 2014 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that Professor Eberhart Zrenner, Retina Implant's co-founder and lead clinical trial investigator and founding director of the Institute of Ophthalmic Research, University of Tuebingen, Germany, presented...

2014-06-23 04:20:48

Retina Implant AG's Lead Clinical Trial Investigator Presents Patient Experiences with the Alpha IMS Subretinal Implant LONDON, June 23, 2014 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that Professor Eberhart Zrenner, Retina Implant's co-founder and lead clinical trial investigator and founding director of the Institute of Ophthalmic Research, University of Tuebingen, Germany,...

2014-05-12 04:21:49

CEO Walter-G Wrobel Shares Patient Results with Subretinal Implants at the 2014 French Society of Ophthalmology (SFO) Congress PARIS, May 12, 2014 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that Walter-G Wrobel, CEO of Retina Implant AG, presented results from the Company's clinical trial for the first time in France at the 120th Congress of the French Society of Ophthalmology...

2014-04-06 20:20:30

Leading Ophthalmologists Provide an Update on Breakthroughs in Artificial Vision Research TOKYO, April 6, 2014 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that Professor Eberhart Zrenner, M.D., coordinating investigator and founding director of the Institute for Ophthalmologic Research at University Eye Hospital, Tuebingen, Germany, presented an update on breakthroughs in artificial...

2014-03-10 04:21:19

Angelika Braun Discusses Patient Outcomes with Subretinal Implants at the XVII Congreso de Sociedad Espanola de Retina y Vitreo (SERV) 2014 SEVILLA, Spain, March 10, 2014 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that Angelika Braun, clinical engineer at Retina Implant AG, presented results from the Company's multicenter clinical trial for the first time in Spain at the XVII...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related